Description

Many MedTech startups focus on “getting the green light” and stop short of what investors and strategics actually care about: durable market adoption and exit-ready value creation. Our panel of industry professionals will discuss how CEOs and founders can navigate the strategic tradeoffs between market authorization and market adoption, and why aligning these decisions early is critical to building an asset buyers want to acquire, not just what product regulators allow you to sell. 

Join CLA, Avio, BayCath Medical, and Mobius Medical as we examine practical exit strategies in MedTech, highlighting how integrated regulatory, clinical, commercial, and financial decisions — rather than isolated milestones — can enhance company value. 

Who should attend 

• Medtech leaders who want to think beyond clearance and structure their companies for adoption, revenue, and transaction readiness 
• Medtech ecosystem partners who want to learn leading practices to support industry growth and success 

Schedule 

11:30 a.m. — Registration and networking
11:45 a.m. — Lunch
Noon – 1 p.m. — Lunch and panel discussion
1 p.m. — Networking
2 – 4 p.m. — Optional Office Hours
4 p.m. — Event conclusion

Register Now